This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Organigram has stopped the production of Jolts in its current format and is currently working with Health Canada on timing to sell through remaining inventory to provincial distributors.
Through its strategic investment in Phylos Bioscience, a U.S.-based leader in cannabis genetics, Organigram cultivates and extracts THCV at its facility in Moncton, New Brunswick.
Organigram said Trailblazer’s modernized brand identity and revitalized product lineup represent an opportunity to connect with consumers whose needs were previously unmet by the company's brand portfolio.
Organigram Holdings Inc. has launched Monjour, the company’s new wellness brand offering CBD-forward products for consumers seeking convenient ways to incorporate CBD into their daily wellness routine.